Evolutionary Genomics, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020
November 14, 2020 at 01:18 am IST
Share
Evolutionary Genomics, Inc. announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced operating loss was USD 474,509 compared to USD 162,511 a year ago. Net income was USD 535,885 compared to net loss of USD 156,321 a year ago. Basic earnings per share from continuing operations was USD 0.08 compared to basic loss per share from continuing operations of USD 0.04 a year ago. For the nine months, operating loss was USD 1.014 million compared to USD 546,189 a year ago. Net loss was USD 729 compared to USD 538,463 a year ago. Basic loss per share from continuing operations was USD 0.04 compared to USD 0.13 a year ago.
Evolutionary Genomics, Inc. is a genomics research and development company. The Company is focused on the identification and validation of genes that impact commercially traits in crops for the agriculture industry. It uses the Adapted Traits Platform (ATP) to identify commercially valuable genes that control important traits in animals and plants. Its platform identifies genes that have changed successfully to impart new or improved traits. The Company has applied its ATP in research projects, including identifying genes responsible for increases in yield in corn, increases in yield in rice, drought tolerance and sugar content in tomatoes and pest/disease resistance in soybeans, cassava, beans, tomatoes, and cotton. The Company uses ATP to perform throughput molecular evolution analysis to identify positively selected genes based on non-synonymous site (Ka) and synonymous site (Ks) analysis.
EVOLUTIONARY GENOMICS, INC. 
